Nektar Therapeutics stock forecast
Nektar Therapeutics (NKTR) Stock Forecast & Price Target
NKTR Analyst Ratings
NKTR Stock 12 Month Forecast
Average Price Target
CHF110.86▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Arthur He CFA | H.C. Wainwright | CHF155.47 | buy | ― | Reiterated | 11/16/26 | ||
| Edward Nash | Canaccord Genuity | CHF128.57→CHF125.21 | buy | ― | Reiterated | 11/16/26 | ||
| Oppenheimer | CHF117.65 | buy | ― | Reiterated | 11/13/26 | |||
| Yasmeen Rahimi | Piper Sandler | CHF161.35 | buy | ― | Reiterated | 11/13/26 | ||
| Martin Fan | Wedbush | CHF42.02→CHF33.61 | hold | ― | Reiterated | 11/13/26 | ||
| Will Soghikian | Leerink Partners | CHF109.25 | buy | ― | Reiterated | 11/13/26 | ||
| Alice Nettleton | UBS | CHF44.54 | hold | ― | Initiated | 10/11/26 | ||
| Julian Harrison | BTIG | CHF149.58 | buy | ― | Reiterated | 10/09/26 | ||
| Thomas Deal | Raymond James | ― | hold | ― | Initiated | 10/08/26 | ||
| Samantha Semenkow | Citi | CHF126.89 | buy | ― | Reiterated | 10/05/26 | ||
| B. Riley Securities | CHF126.05 | buy | ― | Reiterated | 10/02/26 | |||
| Andy Hsieh | William Blair | ― | buy | ― | Reiterated | 10/01/26 | ||
| Roger Song | Jefferies | CHF126.05 | buy | ― | Reiterated | 10/01/26 | ||
| Jessica Fye | J.P. Morgan | CHF54.62 | hold | ― | Initiated | 08/21/26 | ||
| Marc Frahm | TD Cowen | ― | buy | ― | Reiterated | 08/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Arthur He CFAH.C. Wainwright | BuyReiteratedCHF155.47 | 11/16/26 | ― | ||
| Edward NashCanaccord Genuity | BuyReiteratedCHF128.57→CHF125.21 | 11/16/26 | ― | ||
| BuyReiteratedCHF117.65 | 11/13/26 | ― | |||
| Yasmeen RahimiPiper Sandler | BuyReiteratedCHF161.35 | 11/13/26 | ― | ||
| Martin FanWedbush | HoldReiteratedCHF42.02→CHF33.61 | 11/13/26 | ― | ||
| Will SoghikianLeerink Partners | BuyReiteratedCHF109.25 | 11/13/26 | ― | ||
| Alice NettletonUBS | HoldInitiatedCHF44.54 | 10/11/26 | ― | ||
| Julian HarrisonBTIG | BuyReiteratedCHF149.58 | 10/09/26 | ― | ||
| Thomas DealRaymond James | HoldInitiated | 10/08/26 | ― | ||
| Samantha SemenkowCiti | BuyReiteratedCHF126.89 | 10/05/26 | ― | ||
| BuyReiteratedCHF126.05 | 10/02/26 | ― | |||
| Andy HsiehWilliam Blair | BuyReiterated | 10/01/26 | ― | ||
| Roger SongJefferies | BuyReiteratedCHF126.05 | 10/01/26 | ― | ||
| Jessica FyeJ.P. Morgan | HoldInitiatedCHF54.62 | 08/21/26 | ― | ||
| Marc FrahmTD Cowen | BuyReiterated | 08/13/26 | ― |
Best Analysts Covering Nektar Therapeutics
Copying Arthur He CFA's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of +26.38% per trade.
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +143.14% per trade.
Copying Yasmeen Rahimi's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +48.20% per trade.
NKTR Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 11 | 15 | 18 | 16 |
| Buy | 2 | 2 | 2 | 3 | 1 |
| Hold | 1 | 2 | 3 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 15 | 20 | 26 | 21 |
In the current month, NKTR has received 17 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. NKTR average Analyst price target in the past 3 months is 110.86.
NKTR Financial Forecast
NKTR Earnings Forecast
Next quarter’s earnings estimate for NKTR is -CHF 2.07 with a range of -CHF 2.94 to -CHF 1.43. The previous quarter’s EPS was -CHF 1.37. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NKTR Sales Forecast
Next quarter’s sales forecast for NKTR is CHF 7.75M with a range of CHF 6.39M to CHF 10.09M. The previous quarter’s sales results were CHF 7.89M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

